Table 3 Comparative analysis of the KEGG pathways enriched in the three groups
Group | Total | Payhway ID | Pathway description |
|---|---|---|---|
S & A & SA | 25 | ko00100 | Steroid biosynthesis |
ko05332 | Graft-versus-host disease | ||
ko04657 | IL-17 signaling pathway | ||
ko00512 | Mucin type O-glycan biosynthesis | ||
ko05133 | Pertussis | ||
ko05330 | Allograft rejection | ||
ko05320 | Autoimmune thyroid disease | ||
ko00660 | C5-Branched dibasic acid metabolism | ||
ko00520 | Amino sugar and nucleotide sugar metabolism | ||
ko05322 | Systemic lupus erythematosus | ||
ko00260 | Glycine, serine and threonine metabolism | ||
ko03430 | Mismatch repair | ||
ko04111 | Cell cycle - yeast | ||
ko01200 | Carbon metabolism | ||
ko01230 | Biosynthesis of amino acids | ||
ko00909 | Sesquiterpenoid and triterpenoid biosynthesis | ||
ko00680 | Methane metabolism | ||
ko04110 | Cell cycle | ||
ko03030 | DNA replication | ||
ko04940 | Type I diabetes mellitus | ||
ko04612 | Antigen processing and presentation | ||
ko00052 | Galactose metabolism | ||
ko04964 | Proximal tubule bicarbonate reclamation | ||
ko00643 | Styrene degradation | ||
ko00240 | Pyrimidine metabolism | ||
A & S | 2 | ko03050 | Proteasome |
ko04115 | p53 signaling pathway | ||
S & SA | 3 | ko00051 | Fructose and mannose metabolism |
ko00010 | Glycolysis / Gluconeogenesis | ||
ko00250 | Alanine, aspartate and glutamate metabolism | ||
A & SA | 18 | ko04650 | Natural killer cell mediated cytotoxicity |
ko00072 | Synthesis and degradation of ketone bodies | ||
ko05166 | HTLV-I infection | ||
ko04113 | Meiosis - yeast | ||
ko00230 | Purine metabolism | ||
ko00531 | Glycosaminoglycan degradation | ||
ko02026 | Biofilm formation - Escherichia coli | ||
ko04145 | Phagosome | ||
ko05203 | Viral carcinogenesis | ||
ko05169 | Epstein-Barr virus infection | ||
ko03420 | Nucleotide excision repair | ||
ko01524 | Platinum drug resistance | ||
ko00480 | Glutathione metabolism | ||
ko05416 | Viral myocarditis | ||
ko05168 | Herpes simplex infection | ||
ko03460 | Fanconi anemia pathway | ||
ko03440 | Homologous recombination | ||
ko05130 | Pathogenic Escherichia coli infection | ||
S | 9 | ko05310 | Asthma |
ko00710 | Carbon fixation in photosynthetic organisms | ||
ko04060 | Cytokine-cytokine receptor interaction | ||
ko04512 | ECM-receptor interaction | ||
ko00720 | Carbon 2fixation pathways in prokaryotes | ||
ko00410 | beta-Alanine metabolism | ||
ko04141 | Protein processing in endoplasmic reticulum | ||
ko00910 | Nitrogen metabolism | ||
ko00590 | Arachidonic acid metabolism | ||
A | 6 | ko00511 | Other glycan degradation |
ko00513 | Various types of N-glycan biosynthesis | ||
ko04668 | TNF signaling pathway | ||
ko05164 | Influenza A | ||
ko00980 | Metabolism of xenobiotics by cytochrome P450 | ||
ko00650 | Butanoate metabolism | ||
SA | 12 | ko04978 | Mineral absorption |
ko00640metabolism | Propanoate | ||
ko02020 | Two-component system | ||
ko00630 | Glyoxylate and dicarboxylate metabolism | ||
ko05144 | Malaria | ||
ko04514 | Cell adhesion molecules (CAMs) | ||
ko00363 | Bisphenol degradation | ||
ko05410 | Hypertrophic cardiomyopathy (HCM) | ||
ko00521 | Streptomycin biosynthesis | ||
ko00290 | Valine, leucine and isoleucine biosynthesis | ||
ko00500 | Starch and sucrose metabolism | ||
ko00770 | Pantothenate and CoA biosynthesis |